What is Tianjin Chase Sun Pharmaceutical Co Operating Cash Flow per Share?
Tianjin Chase Sun Pharmaceutical Co's operating cash flow per share for the
three
months ended in Mar. 2024 was ¥0.05.
Tianjin Chase Sun Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.43.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tianjin Chase Sun Pharmaceutical Co was 39.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 99.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 37.80% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 16.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Tianjin Chase Sun Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:
SZSE:300026'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -35.9 Med: 38.1 Max: 317.9
Current: 99.1
During the past 13 years, Tianjin Chase Sun Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 317.90% per year. The lowest was -35.90% per year. And the median was 38.10% per year.
SZSE:300026's 3-Year OCF Growth Rate is ranked better than 97.14% of 804
companies
in the Drug Manufacturers industry
Industry Median: 7.55
vs SZSE:300026: 99.10
Tianjin Chase Sun Pharmaceutical Co Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Tianjin Chase Sun Pharmaceutical Co Operating Cash Flow per Share Chart
Competitive Comparison of Tianjin Chase Sun Pharmaceutical Co's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Tianjin Chase Sun Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.
Tianjin Chase Sun Pharmaceutical Co Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.43
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Chase Sun Pharmaceutical Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Tianjin Chase Sun Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Tianjin Chase Sun Pharmaceutical Co (SZSE:300026) Business Description
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300026 has been successfully added to your 